Literature DB >> 19415960

Epithelioid sarcoma.

Henry B Armah1, Anil V Parwani.   

Abstract

Epithelioid sarcomas are rare, mesenchymal tumors of unknown histogenesis and display multidirectional differentiation, which is predominantly epithelial. They have no normal cellular counterpart and differ from both synovial sarcoma and carcinoma. They account for less than 1% of all soft tissue sarcomas and are usually slow growing, with peak incidence in young adult men and occur predominantly in extremities. Histologically, they form nodules, with central necrosis surrounded by bland, polygonal cells with eosinophilic cytoplasm and peripheral spindling. They regularly express vimentin, cytokeratins, epithelial membrane antigen, and CD34, whereas staining is usually negative with S100, desmin, and FLI-1. Ultrastructurally, they display epithelial and mesenchymal features, including myofibroblastic differentiation. They manifest no specific cytogenetic findings, but several cases have displayed chromosomal abnormalities in 22q region. Clinically, they have a high recurrence rate, and up to 50% of epithelioid sarcomas metastasize. Proximal, fibroma-like, and angiomatoid variants have been described. The proximal variant (with larger cells, prominent nucleoli, and rhabdoid changes) is clinically more aggressive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415960     DOI: 10.5858/133.5.814

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  25 in total

1.  Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer.

Authors:  Langmei Deng; Tao Su; Aimin Leng; Xiaomei Zhang; Meihua Xu; Lu Yan; Huan Gu; Guiying Zhang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

2.  Magnetic resonance and computed tomography imaging features of epithelioid sarcoma in children and young adults with pathological and clinical correlation: a report from Children's Oncology Group study ARST0332.

Authors:  M Beth McCarville; Simon C Kao; Tuan V Dao; Christopher Gaffney; Cheryl M Coffin; David M Parham; Andrea Hayes-Jordan; Sheri L Spunt
Journal:  Pediatr Radiol       Date:  2019-03-30

3.  Epithelioid Sarcoma in the Cervical Spine: A Case Report.

Authors:  Chungnam Lee; Woo Jin Choe; Nara Kim
Journal:  Korean J Spine       Date:  2015-09-30

4.  Soft tissue angiofibroma: a case report.

Authors:  Jonathan J Lee; Miriam A Bredella; Dempsey S Springfield; Gunnlauger P Nielsen
Journal:  Skeletal Radiol       Date:  2013-10-10       Impact factor: 2.199

5.  Primary pleural epithelioid sarcoma of the proximal type: a diagnostic and therapeutic challenge.

Authors:  Zeeshan Ahmad; Qasim Stanazai; Staphanie Wright; Matthew Smolkin; Patrick C Ma
Journal:  Transl Lung Cancer Res       Date:  2019-10

6.  Proximal-type Epithelioid Sarcoma Arising in the Inguinal Area.

Authors:  Ji-Ye Kim; Seum Chung; Hoon-Bum Lee; Yoon-Kyu Chung
Journal:  Arch Plast Surg       Date:  2012-03-14

7.  Recurrent epithelioid sarcoma in the thoracic spine successfully treated with multilevel total en bloc spondylectomy.

Authors:  Pongsthorn Chanplakorn; Niramol Chanplakorn; Atcharaporn Pongtippan; Suphaneewan Jaovisidha; Wichien Laohacharoensombat
Journal:  Eur Spine J       Date:  2011-02-18       Impact factor: 3.134

8.  Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Luis Rubio; Jorge Campos; María Barrios; Camille Grison; Virginie Chene; Gaelle Pierron; Olivier Delattre; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2013-11-10       Impact factor: 4.064

9.  Management of Epithelioid Sarcoma of the Inguinal Region with Vascular Invasion.

Authors:  Amit Mahajan; Indrani Sen; Darpanarayan Hazra; Sunil Agarwal
Journal:  Indian J Surg       Date:  2015-11-12       Impact factor: 0.656

Review 10.  Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy.

Authors:  Jonathan Noujaim; Khin Thway; Zia Bajwa; Ayeza Bajwa; Robert G Maki; Robin L Jones; Charles Keller
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.